-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Galectin Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$12.4M, a 35.7% decline year-over-year.
- Galectin Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$44.3M, a 11.1% decline year-over-year.
- Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$41.1M, a 5.91% decline from 2022.
- Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$38.8M, a 27% decline from 2021.
- Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.5M, a 30.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)